SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    5.60 (3.29%)
Bid:
176.00
Ask:
176.60
Spread: 0.60 (0.341%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Debt Prospectus

23 Apr 2020 16:25

RNS Number : 7062K
Jupiter Fund Management PLC
23 April 2020
 

Publication of Prospectus

Jupiter Fund Management plc

23 April 2020

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

Publication of Prospectus

The following prospectus has been approved by the UK Listing Authority and is available for viewing:

Prospectus dated 23 April 2020 (the "Prospectus") relating to the Jupiter Fund Management plc issue of £50,000,000 8.875 per cent. Fixed Rate Reset Callable Subordinated Notes due 2030.

 A copy of the Prospectus is available for viewing at:

http://www.rns-pdf.londonstockexchange.com/rns/7062K_1-2020-4-23.pdf

 

For further information, please contact:

 

 

 

Investors

Media

 

 

Jupiter

Alex Sargent/Investor Relations

+44 (0)20 3817 1534/1065

Despina Constantinides/Corporate Communications

+44 (0)20 3817 1196/1278

 

 

 

 

Powerscourt

Justin Griffiths

+44 (0)20 7549 0999

 

 

 

 

 

 

 

 

 

       

 Important Notices

This announcement is an advertisement and for information only and does not constitute or form part of, and should not be construed as, an offer to sell nor is it a solicitation of an offer to buy securities in any jurisdiction where it is unlawful to do so.

The offering and the distribution of this announcement only to and directed only at persons in circumstances where sections 21(1) of the Financial Services and Markets Act 2000, as amended, does not apply (all such persons together being referred to as "relevant persons"). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity in the United Kingdom (including, but not limited to, any invitation, offer or agreement to subscribe, purchase or otherwise acquire securities) to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

PROHIBITION OF SALES TO EUROPEAN ECONOMIC AREA (THE "EEA") AND UNITED KINGDOM (THE "UK") RETAIL INVESTORS - The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA or in the UK. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive (EU) 2014/65 (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or in the UK may be unlawful under the PRIIPs Regulation.

MIFID II product governance / Professional investors and ECPs only target market - Solely for the purposes of the manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a "distributor") should take into consideration the manufacturer's target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturer's target market assessment) and determining appropriate distribution channels.

This announcement is not an offer of securities for sale in the United States or in any other jurisdiction to whom or in which such offer or solicitation is unlawful and is not for publication or distribution to U.S. persons (within the meaning of Regulation S under the Securities Act). The Notes have not been and will not be registered under the Securities Act and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDIKKNBBPBKDQQB
Date   Source Headline
10th Jun 20263:15 pmRNSTransaction in Own Shares - Replacement
9th Jun 202612:15 pmRNSHolding(s) in Company
8th Jun 20264:00 pmRNSTransaction in Own Shares
2nd Jun 20265:19 pmRNSHolding(s) in Company
1st Jun 202611:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSTotal Voting Rights
28th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20263:45 pmRNSTransaction in Own Shares
18th May 20263:30 pmRNSTransaction in Own Shares
11th May 20264:57 pmRNSTransaction in Own Shares
8th May 20264:00 pmRNSHolding(s) in Company
7th May 20263:30 pmRNSHolding(s) in Company
7th May 20261:00 pmRNSResult of AGM
5th May 20264:00 pmRNSTransaction in Own Shares
5th May 20263:00 pmRNSHolding(s) in Company
5th May 20262:45 pmRNSHolding(s) in Company
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20262:45 pmRNSHolding(s) in Company
28th Apr 202612:45 pmRNSHolding(s) in Company
27th Apr 20264:02 pmRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTrading Update and Notice of Results
20th Apr 202612:20 pmRNSTransaction in Own Shares
14th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:00 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSShare Buyback Programme
1st Apr 20263:00 pmRNSDirector/PDMR Shareholding
30th Mar 20263:00 pmRNSDirector/PDMR Shareholding
27th Mar 20263:30 pmRNSDirector/PDMR Shareholding
26th Mar 202612:12 pmRNSHolding(s) in Company
25th Mar 20264:51 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
24th Mar 20262:00 pmRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20262:00 pmRNSHolding(s) in Company
4th Mar 202612:30 pmRNSHolding(s) in Company
4th Mar 202612:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
27th Feb 20263:30 pmRNSDirector Shareholding
27th Feb 20263:15 pmRNSTotal Voting Rights
26th Feb 20265:00 pmRNSCancellation of Treasury Shares
26th Feb 20267:00 amRNSAnnual Financial Report
9th Feb 20263:45 pmRNSHolding(s) in Company
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
5th Feb 20262:42 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20261:30 pmRNSHolding(s) in Company
2nd Feb 20269:53 amRNSCompletion of Acquisition of CCLA
22nd Jan 20262:04 pmRNSHolding(s) in Company
7th Jan 20263:15 pmRNSHolding(s) in Company
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.